News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Rhythm Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
Is There a Biotech Bubble Brewing in Boston?
Billions of dollars are being invested in Boston-based life science companies.
March 21, 2018
·
2 min read
·
Alex Keown
Deals
Pfizer Quietly Takes Additional Stake in This Boston Pharma
Pfizer has increased its stake in Rhythm Pharmaceuticals.
October 19, 2017
·
2 min read
·
Alex Keown
Deals
Boston Rare Disease Biopharma Rhythm Seeks $115 Million IPO
September 6, 2017
·
1 min read
Deals
Boston’s Rhythm Withdraws $86 Million IPO Citing Acquisition Agreement With Actavis
October 30, 2014
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026
June 15, 2026
·
14 min read
Press Releases
Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
June 15, 2026
·
12 min read
Press Releases
Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome
June 14, 2026
·
8 min read
Press Releases
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
May 29, 2026
·
10 min read
Press Releases
Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics
May 28, 2026
·
10 min read
Press Releases
Rhythm Pharmaceuticals Announces Participation in Upcoming June 2026 Investor Conferences
May 26, 2026
·
7 min read
Press Releases
Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
May 12, 2026
·
12 min read
Press Releases
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
May 6, 2026
·
7 min read
Press Releases
Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
May 5, 2026
·
20 min read
Press Releases
Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society
May 4, 2026
·
10 min read